JuveLook PDLLA Booster | Pore Minimizing, Collagen Neogenesis, and Skin Texture Improvement

A common frustration for many is skin that appears coarse, dull, and plagued by enlarged pores. These concerns are fundamentally rooted in collagen depletion. JuveLook PDLLA Booster is a specialized aesthetic treatment designed to trigger the skin’s biological ability to regenerate its own collagen.

Pore Refinement

Dermal Collagen Depletion

Beneath the surface lies a dermal layer 1.5 to 2.0 mm thick, where collagen accounts for 70% of its dry weight. Once we pass the age of 25, the body’s collagen synthesis slows by 1.5% annually, causing the skin’s underlying reticular structure to develop microscopic voids. Type I collagen acts as the “rebar” of the skin, making up 80% to 85% of the total volume with fibers 50 to 500 nm thick. Type III collagen is finer (30 to 100 nm) and functions like “elastic bands” encircling the pores. In adulthood, Type III collagen levels plummet from a youthful 50% to less than 15%, causing the structural integrity of the pore opening to fail. UVA rays (320 to 400 nm) penetrate deep into the dermis, activating a destructive enzyme called MMP-1 that shears through collagen fibers. When these fibers snap, a once-circular 0.02 mm pore loses its support and collapses. Gravity exerts a constant downward force of 9.8 m/s² on the face. Pores that have lost their elasticity stretch into tear-drop shapes exceeding 0.3 mm in length. As the dermis thins by just 0.5 mm, light reflectivity drops by 25%, leaving the complexion looking rough, sallow, and yellowish. Standard skincare products often have molecular weights exceeding 500 Daltons, while the gaps in the skin’s outermost barrier are only 15 to 50 nm wide. Large molecules simply cannot penetrate. Restoring collagen lost 1.2 mm deep in the dermis requires optimizing the subcutaneous environment.

• Daily blue light exposure from screens exceeding 6 hours.
• Sugar consumption leading to Advanced Glycation End-products (AGEs).
• A 15% drop in blood oxygen levels within facial capillaries.
• Excessive sebum production damaging the skin’s protective barrier.
• A reduction in dermal thickness exceeding 20%.

Each of JuveLook contains 42.5 mg of PDLLA microspheres, precisely sized between 10 and 40 microns. These spheres feature a porous, honeycomb-like architecture with internal channels 1 to 5 microns wide—perfectly sized for cells to migrate into. Once inside, these cells trigger the release of a growth signal known as TGF-beta 1. The signaled cells then begin an intensive cycle of collagen production. The formula also includes 7.5 mg of Hyaluronic Acid (HA); 1 gram of HA can hold up to 6 liters of water. This immediately plumps up depleted gaps in the tissue, significantly increasing skin hydration within 48 hours. Doctors utilize an ultra-fine 34G, just 0.18 mm in diameter. With a bevel less than 0.5 mm long, it minimizes tissue trauma during a full-face treatment of over 100 injection points. Each point receives a precise 0.0125 ml dose deposited exactly 1.0 to 1.2 mm deep. By day 7, fibrin begins to accumulate around the microspheres. By day 28, new collagen fibers intertwine within the pores of the spheres. By day 90, ultrasound scans reveal a visibly thickened and more robust dermis. Collagen growth typically reaches its peak between months 3 and 4.

• Declining fibroblast activity after age 25.
• Increased UV-induced enzymatic degradation.
• Disorganized fiber networks in the reticular dermis.
• A 30% reduction in localized skin elasticity.
• Weakened structural support around sweat gland ducts.

PDLLA eventually metabolizes into lactic acid, which is processed by the body and excreted as water and carbon dioxide. After one year, less than 5% of the material remains, yet the newly grown tissue—averaging a steady 0.2 mm in thickness—persists. While a 30-year-old may have pores 0.12 mm wide, three sessions of PDLLA can refine them down to 0.05 mm. Skin roughness decreases by approximately 40%, and the height of the papillary dermis recovers from 150 microns back to 180 microns. The surface area of these porous microspheres is six times that of a solid sphere, allowing for greater interaction with immune cells. Stimulated monocytes release IL-10, and over months of regeneration, the ratio of collagen types shifts back toward a more youthful profile. The dermis is rich in microvessels that transport nutrients. Aging can reduce vessel density by 15%, cutting off the “supply line” for collagen synthesis. Without these nutrients, the pore walls become as fragile as a hollow brick wall lacking mortar. Injection depth must be flawless. Depositing the material too shallowly (above 0.5 mm) can lead to visible nodules, while injecting too deeply into the fat (below 3 mm) renders the treatment ineffective. A steady hand ensures the PDLLA forms an even, supportive mesh beneath the skin.

• Slow “snap-back” or skin recoil during facial expressions.
• “Orange peel” texture visible under side-lighting.
• Parallel fine lines appearing when the cheek is pushed upward.
• Makeup “pitting” where foundation settles visibly into pores.

Dual-Action Ingredient Analysis

Inside a JuveLook are two ingredients with completely different physical properties. Using vacuum freeze-drying technology at -50°C and 0.1 atm, 42.5 mg of Poly-D,L-Lactic Acid (PDLLA) and 7.5 mg of non-crosslinked Hyaluronic Acid (HA) are solidified into a white cake. Before use, this is reconstituted with 5 ml of 0.9% medical-grade saline. The is placed in a dedicated vortex mixer at 2,000 RPM for 30 continuous minutes. As the powder absorbs water and expands, it transforms into a translucent, milky suspension. Tests show a stable pH of approximately 7.25, perfectly mirroring the acidity of facial interstitial fluid. Once injected 1.2 mm deep into the superficial dermis, the 7.5 mg of non-crosslinked HA acts first. With a molecular weight of 1 to 1.5 million Daltons, it migrates into the intercellular spaces and, within 2 hours, captures free water molecules weighing 1,000 times its own mass. During the first three days, aged, droplet-shaped pores (those exceeding 0.3 mm) are rounded out by immediate hydraulic pressure. Epidermal moisture levels surge from a baseline of 15% to over 45%. Enzymes then metabolize the HA at a rate of 4 units per hour, clearing the way for long-term tissue growth. By day 14, most of the free water has drained through the lymphatic system. At this point, the 42.5 mg of PDLLA takes over. These millions of micro-spheres operate on a distinct biological timeline:

Under a microscope, the PDLLA particles are strictly confined to the 10–40 micron range. This sizing is strategic: a typical macrophage is about 15 microns long and cannot easily engulf a 40-micron particle. This prevents the material from being prematurely cleared, allowing it to remain stable in the dermis. If particles exceed 50 microns, they tend to clump in the reticular dermis, forming visible nodules. If they are smaller than 10 microns, they cannot withstand the 20 mmHg of tissue pressure. The 10–40 micron range allows the particles to wedge perfectly into the 20-micron microscopic gaps between dermal fiber bundles. The porous, sponge-like structure of the microspheres leaves 45% of their internal volume empty. This increases the contact surface area six-fold compared to solid spheres. Interstitial fluid flows into these pores, drawing fibroblasts into the spheres’ interior. By day 28, fibroblasts anchor themselves to the pore walls, secreting approximately 2.5 μg of Type I collagen daily. These new protein filaments, 1 to 10 microns thick, weave through and around the microspheres. Millions of these spheres become encased in autologous tissue, acting like stable “organic cocoons.” These cocoons create a 0.2 mm thick elastic fiber wall around the pores. Large pores that once measured over 0.15 mm are compressed inward by this new tissue. Skin diagnostics show that by day 90, actual pore diameter is often reduced to below 0.05 mm. PDLLA undergoes hydrolysis upon contact with moisture. Over 180 days, the microspheres dissolve at an ultra-slow rate of less than 0.05 mg per day, releasing L-lactic and D-lactic acid molecules. This gentle acidic environment keeps local pH fluctuations within 0.1, preventing inflammation and swelling. The lactic acid eventually enters the Krebs cycle, metabolizing into carbon dioxide (exhaled) and water (excreted). After 240 days, no detectable chemical residue remains. By then, the net weight of new collagen per square centimeter has increased by 30%, with the voids filled entirely by an autologous collagen scaffold. This newly constructed “collagen floor” supports the skin for 12 to 18 months. Spreading 5 ml of suspension precisely across the face requires rigorous injection technique:

• Maintain a 15- to 20-degree angle with the bevel facing up.
• Keep a precise 1.0 cm distance between injection points.
• Maintain a steady injection speed of 0.01 ml per second.
• Avoid dense vascular zones located 0.8 mm below the surface.

Aggressive injection pressure can cause 3 mm wide fluid bumps, potentially snapping aged fibers and causing 0.1 mm micro-tears at the pore edges. Conversely, injecting too slowly allows the powder to settle at the bottom of the, resulting in uneven distribution. Practitioners use 34G ultra-fine with wall thicknesses of only 0.04 mm. Post-injection, nurses apply sterile ointment and 2 to 3 kg of pressure. Massaging the cheeks for 5 to 8 minutes ensures the liquid pockets 1.2 mm deep disperse to a radius of 1.5 cm.

The Collagen Regeneration Cycle

In the first 24 to 48 hours, the environment 1.2 mm beneath the skin undergoes a massive restructuring. The 7.5 mg of non-crosslinked HA acts as a series of “micro-anchors,” drawing in surrounding fluid and increasing local blood flow by roughly 15%. During this phase, dermal pH shifts slightly from 7.35 to 7.1. This subtle change signals immune cells that new materials have arrived. Pores that were once 0.3 mm wide appear temporarily smoothed due to this immediate hydration.

Between day 7 and day 14, many patients feel the results are “fading.” This occurs because the 7.5 mg of HA has been largely metabolized, and the initial water-induced plumpness is receding. This is a normal transition period, clearing space for actual tissue growth.

The millions of PDLLA microspheres (10–40 μm) are now anchoring into the tissue. The 20 mmHg of tissue pressure keeps them locked in the superficial dermis. Their porous structure provides 600% more surface area for attachment than solid particles.

• Precise positioning of 10–40 μm microspheres.
• Fibrin encapsulation beginning at Day 7.
• Rising concentrations of growth signals after Day 14.
• 20 mmHg of pressure preventing sphere migration.
• 1.2 mm depth to avoid the 0.8 mm vascular layer.

By day 28, fibroblasts have migrated into the 1–5 μm pores of the spheres. Stimulated by the mild lactic acid environment, they secrete roughly 2.5 μg of fine Type I collagen (50–500 nm) every day.

Microscopic biopsies at this stage show collagen density around the PDLLA spheres is 18% higher than in untreated areas. The structural rings at the base of the pores begin to thicken, pushing the once-sagging pore walls back toward the center.

The window between day 60 and day 90 is the “growth surge.” As the 42.5 mg of PDLLA slowly dissolves (0.05 mg/day), the space it vacates is immediately occupied by new collagen. The result is a dense, “self-grown” filler that occupies the previously hollowed subcutaneous space.

• Day 28: Initiation of protein transcription.
• Day 60: Initial crossing of the fiber mesh.
• Day 90: Peak tissue volume increase.
• Day 180: Material degradation reaches 50%.
• Day 240: Particles are virtually metabolized.

Data indicates that 90 days after a three-session protocol, the papillary dermis height can recover from 150 μm to over 180 μm. Surface roughness (Ra) drops from 1.2 μm to 0.7 μm—a nearly 40% improvement—while 0.12 mm pores contract to less than 0.05 mm.

The body possesses its own “regulatory valves” to prevent overgrowth. As fiber density around the pores returns to youthful levels, growth signals naturally taper off. This braking mechanism ensures facial contours remain smooth without developing hard lumps.

Between day 180 and day 240, the PDLLA completes its mission. It hydrolyzes into lactic acid and is excreted as $CO_2$ and water. Though the material is gone, it leaves behind a 0.2 mm “autologous scaffold”—living tissue, not a temporary filler. This new collagen foundation restores the youthful ratio of Type I to Type III collagen, increasing the strength of elastic fibers around the pores by approximately 30%.

• 0.2 mm net increase in dermal thickness.
• 30% increase in elastic fiber strength.
• Long-term support exceeding 540 days.
• 15% compensatory rise in microvascular density.
• Epidermal fluctuations maintained within 0.1 mm.

Microvascular density also increases by 15%, essentially building “new highways” for nutrient delivery and waste removal. This ensures that even after the 42.5 mg of material has vanished, fibroblasts have the nutrients required for normal maintenance. While UV exposure still “steals” 1% of collagen annually, the skin’s tensile strength remains significantly higher than the pre-treatment baseline for at least 18 months. The newfound tightness does not collapse when the agent dissolves because the underlying foundation has been structurally rebuilt.

Doctors must maintain a strict dosage of 0.0125 ml per point. This multi-point, micro-dose approach ensures that collagen regeneration begins across the entire face on a synchronized timeline. Inconsistent dosing creates uneven tension, resulting in a disorganized and ineffective collagen network.

Collagen Neogenesis

Precision Microsphere Mechanism

A clinical assistant reconstitutes 42.5 mg of PDLLA powder with 5 ml of sterile saline. At a controlled room temperature of 25°C, the porous particles undergo physical sedimentation for 30 minutes, allowing the suspension’s osmotic pressure to align with the body’s interstitial fluid. The non-crosslinked hyaluronic acid carrier begins to capture water molecules 500 times its volume, forming a homogenous liquid gel. The practitioner utilizes an ultra-fine 32G (0.3 mm outer diameter). The enters the deep dermis at a 45-degree angle, maintaining a depth between 1.5 and 2.5 mm. During injection, a precise 0.03 ml of the suspension is released per point. A single full-face procedure involves approximately 200 to 300 of these micro-injections.

• 32G ultra-fine minimize thermal tissue trauma.
• Precise 42.5 mg PDLLA concentration ratio.
• Targeted delivery to the 1.5–2.5 mm dermal reticular layer.
• 0.03 ml exact dosage per injection point.

Microscopic scans reveal that these microspheres are strictly sized between 10 and 40 microns. This diameter range eliminates the risk of vascular embolism and exceeds the 15-micron phagocytosis limit of individual macrophages. The surface of each particle is densely populated with 1 to 3-micron micropores, creating a sponge-like 3D scaffold for subsequent biological reactions. Within 48 hours of injection, approximately 500,000 macrophages are recruited to the area. Because the microspheres are too large to be engulfed, the macrophages transition to releasing chemical signaling molecules. By Day 7, the concentration of the TGF-β cytokine in the local tissue fluid climbs to 1.3 times its baseline, guiding fibroblasts toward the particles. Fibroblasts migrate through the dermal matrix at a rate of 4 to 6 microns per hour. They use the micropores on the sphere surfaces for physical anchoring, with a single microsphere supporting an average of 15 to 20 active cells.

• 10 to 40 μm particle size distribution.
• Porous surface architecture with 1–3 μm gaps.
• 33% increase in TGF-β concentration by Day 7.
• 20 fibroblasts anchored per microsphere.

The rough endoplasmic reticulum within the fibroblasts enters a state of high-intensity production, assembling amino acid sequences into triple-helix structures. New Type I collagen fibers, with consistent diameters of 50 to 200 nm, crisscross between the microspheres to weave a dense protein support network. Water molecules in the body’s fluids continuously attack the polymer’s internal ester bonds. Over 12 months, the 100,000-Dalton long-chain molecules gradually hydrolyze into low-molecular-weight oligomers. The local pH stabilizes around 6.5; this mildly acidic microenvironment induces the proliferation of capillary endothelial cells, opening “supply lines” for nutrient delivery. The polylactic acid material consists of D-type and L-type isomers. Areas with crystallinity below 30% dissolve within the first 3 months, and the resulting gaps are immediately filled by autologous collagen fibers. As the polymer mass decreases at a rate of approximately 5% per month, the volume of self-generated tissue rises proportionally, achieving a complete biological exchange.

• 50 to 200 nm diameter of newborn fibers.
• 12 to 15-month long-term degradation cycle.
• pH 6.5 mildly acidic regenerative environment.
• Orderly 5% monthly material replacement.

The lactic acid molecules produced during degradation have a molecular weight of only 90 Daltons. These monomers penetrate the 0.1-micron thick capillary endothelium and enter the systemic circulation at a blood flow velocity of 0.5 mm per second. Enzymes in the liver convert them into pyruvate, which eventually undergoes oxidative decomposition in the Krebs cycle. The physical presence of the microspheres gradually vanishes, transforming into pure water and carbon dioxide. 20 MHz high-frequency ultrasound records show the dermal thickness in the treated area increasing from an initial 2.3 mm to 2.65 mm. This 0.35 mm gain consists entirely of new, autologous protein bundles. Physical tensiometers indicate that facial epidermal tension has increased by 18 N/cm². Pores that were previously enlarged due to collagen loss are now compressed inward by the surrounding protein mesh, resulting in a physical reduction in diameter. The transepidermal water loss (TEWL) rate drops by approximately 8%, making the overall skin texture denser and more elastic at a microscopic level.

• 90-Dalton lactic acid monomers enter circulation.
• 0.35 mm net increase in dermal thickness.
• 18 N/cm² improvement in epidermal tension.
• 8% reduction in transepidermal water loss.

Dermal Density and Texture Enhancement

High-frequency 20 MHz ultrasound probes penetrate 4 mm into the cheek area. Before injection, dermal echograms show numerous dark zones and a thickness of 2.15 mm. By Day 90, the echo signal band widens, and dark zones are filled with high-echo spots, with signal intensity rising from 45 dB to 62 dB. Dermal thickness increases by an average of 14.5%, equivalent to an additional 8.5 mg of protein per cubic centimeter. The 0.31 mm gain is attributed entirely to new collagen fibers. The ratio of Type III “infant” collagen recovers from 12% to 18%, eliminating the “tissue-paper” dry texture of aging skin. The protein mesh secreted by fibroblasts shrinks its pore size to the 50–100 nm range, with cross-linking density reaching 400 physical nodes per square micron. These high-density protein bundles withstand 2.5 MPa of internal tension. This extracellular matrix provides 12 Newtons of upward support to the 0.1 mm thick epidermis. The collagen rings surrounding the pores thicken by 15 microns. Pores that had sagged into 150-micron-long “teardrops” are now squeezed by 0.05 Newtons of force from the new protein network. This inward pressure pushes the pore openings toward the center, making them rounder and smaller.

VISIA diagnostic imaging captures the micro-details: the number of large pores per square centimeter on the cheek drops from 45 to 28. Over 90 days, total pore volume is reduced by 22%, and the surface area occupied by pores narrows from 5.2% to 3.8%. Sebum no longer accumulates in dermal depressions but spreads evenly across a smoothed stratum corneum. Free fatty acids decrease by 4 μg/cm². Under macro lenses, the shadow area of blackheads shrinks by 15%, and skin pH stabilizes in the healthy 5.5 acidic range. Intercellular lipid arrangement in the stratum corneum becomes more compact, increasing barrier thickness by 2.5 microns. The water evaporation rate drops significantly, and moisture meter readings improve by 16.5 units. In a 22°C test environment, corneocyte volume expansion reaches approximately 8%. Micro-crevices are plumped to a flat state, with crack depths falling below 10 microns. The previously dry epidermis, pulled by the underlying hydrated collagen matrix, achieves a physically smooth finish. Elasticity tests on the cheekbone show that under 400 mbar of pressure, skin distension is reduced by 0.2 mm. The elasticity coefficient rises from 0.55 to 0.68, while recoil time shortens from 0.45 seconds to 0.30 seconds. The recovery process within a tenth of a second is clearly mapped: the moment negative pressure is removed, the high-density collagen network snaps back. The indentation left by a 500-gram weight on the cheek fades 2.5 minutes faster than it did before the treatment. 3D scans of crow’s feet, taken at 0.01 mm intervals, show the peak-to-valley depth narrowing from 45 microns to 32 microns. Local wrinkle volume is reduced by 0.08 mm³, significantly lowering the light-shadow contrast of epidermal folds. The dense, smooth new stratum corneum causes light incident at an 85-degree angle to form diffuse reflections at a ratio of 78%. Surface gloss readings rise by 12 percentage points, and pigmented areas fade by 4.2%, enhancing overall skin translucency. Soft tissue sagging at the jawline is reduced by 1.2 mm. The physical coordinates of the malar fat pad (apple cheeks) shift 0.8 mm upward and diagonally, with resistance to fat pad displacement increasing by 0.4 kgf. Physical resistance when pinching the skin increases by 25%.

Regeneration Timeline

The enters 1.5 mm sub-dermally at an angle. 42.5 mg of micro-crystals mixed with saline enter the dermis, and the 0.23 mm puncture heals rapidly. Within 72 hours, the hyaluronic acid captures 500 times its weight in water, increasing local hydration by 15.4% and creating a “climate-controlled” environment for cell growth. From Day 3 to Day 7, 500,000 macrophages arrive. Unable to engulf the 10–40 μm microspheres, they begin signaling. By Day 7, signaling factor concentrations spike by 33%, and fibroblasts migrate in droves toward the microsphere surfaces.

• Day 1: Precise placement of 42.5 mg micro-powder.
• Day 3: 500,000 macrophages begin identification.
• Day 7: 33% surge in signaling factor concentration.
• Day 14: Fibroblasts establish permanent residency.

Microscopic observation shows fibroblasts anchored to the sponge-like spheres. Each microsphere features over 200 micro-pores and houses an average of 20 cells. These cells act as “micro-factories,” assembling protein chains every second. These chains weave into tissue gaps, repairing the aging foundation.

At the one-month mark, new collagen fibers (50–200 nm in diameter) have intertwined. Tensiometers measure a pull of 18 Newtons per square centimeter. Corneocytes are propped up from below, increasing in volume by 8%. Transepidermal water loss drops to 12.1 g/m²h, and the skin feels palpably thicker. By month two, the environment pH stabilizes at 6.5, encouraging a 14% increase in microvascular density. These vessels transport essential amino acids and oxygen. Dermal thickness grows from 2.15 mm to 2.46 mm, and the volume of large pores shrinks by 22%.

• Day 28: Epidermal tension increases by 18.5 N.
• Day 60: Microvascular network expands by 14%.
• Day 90: Dermal thickness increases by 0.31 mm.
• Day 120: Total pore volume shrinks by 22%.

3D scanning shows the depth of fine lines around the eyes reduced from 45 μm to 32 μm. Ultrasound signals become denser and strengthen by 17 dB. Voids in the underlying structure are filled with protein—not by an artificial filler, but by the body’s own grown tissue.

The microspheres begin to slowly dissolve. As moisture breaks down the polymer, long chains snap into shorter ones, and the material mass decreases by 5.5% each month. The vacated space is immediately replaced by 20 μg of new collagen produced daily. Around the six-month mark, this exchange reaches equilibrium, and autologous collagen levels peak. After six months, half of the material has metabolized into lactic acid monomers (90 Daltons). These flow through the bloodstream to the liver and are eventually excreted as carbon dioxide and water. Skin radiance improves by 12%, and pigmentation reduces by 4.2%.

• Day 180: 50% of material completes its mission.
• Day 270: Autologous collagen network takes over entirely.
• Day 450: Microspheres are completely exhaled/excreted.
• Day 540: Skin quality maintains 90% of its peak state.

Biopsies at 15 months show 0.8 μg of hyaluronic acid per mg of tissue. This protein network can withstand 3.5 MPa of pressure. Facial tissue sagging is limited to within 1.2 mm. This 500-day regeneration marathon reduces aging-related degradation to an incredibly low 0.01% per day.

Skin Texture Improvement

Optimizing Collagen Neogenesis

JuveLook’s 42.5 mg of PDLLA molecules reach a full suspension when reconstituted in 6 ml to 8 ml of sterile saline. This ratio ensures a distribution of approximately 5 million particles per milliliter. With diameters precisely engineered between 10 and 40 microns, these particles can seamlessly pass through ultra-fine 32G to achieve uniform dispersion at a dermal depth of 1.5 mm to 2.0 mm. The physical morphology of the microspheres resembles a microscopic honeycomb, with surface pores measuring 1 to 5 microns in diameter. This architecture increases the effective surface area by over 20 times compared to standard solid spheres. This porous design provides an expansive scaffold for fibroblast attachment; within 48 hours of implantation, cells begin migrating into and colonizing these micropores, triggering the protein synthesis cascade. Collagen regeneration is not merely an increase in volume but a recalibration of the ratio between key fiber types. By Day 21 post-injection, the local density of Type III collagen typically increases by more than 22%. These fibers, measuring only 30 nm to 100 nm in diameter, are exceptionally soft. The surge of these fine fibers restores an “infant-like” elasticity and suppleness to the skin.

• Type III collagen dominates the first four weeks of tissue neogenesis.
• The honeycomb porosity of PDLLA microspheres increases cell contact area by 2000%.
• The 10–40 μm particle size distribution ensures optimal diffusion within the interstitial spaces.

Over time, this regenerative ratio transitions toward Type I collagen. By approximately Week 12, new Type I fibers begin providing structural support. These fibers are sturdier, with diameters exceeding 1 micron, acting like “biological rebar” to tighten sagging skin. Eventually, the ratio between Type III and Type I collagen stabilizes at roughly 1:3, mirroring the balance found in healthy, youthful skin. The addition of 7.5 mg of non-crosslinked hyaluronic acid (HA) serves as a lubricant, stabilizing local osmotic pressure at 280 to 310 mOsm—matching the body’s natural interstitial fluids. This hydration support prevents the PDLLA microspheres from clumping during the initial phase. The spheres disperse with an average spacing of 50 microns, ensuring a collagen regeneration coverage rate of over 95%. The metabolism of PDLLA is exceptionally gentle. Through hydrolysis, it gradually converts into lactic acid monomers, which are eventually processed through the Krebs cycle into carbon dioxide and water. This metabolic process takes 12 to 18 months. During this period, local pH fluctuations are restricted to within 0.5 units, protecting surrounding nerves and vessels from irritation.

• A 12-to-18-month metabolic cycle allows ample time for the collagen scaffold to solidify.
• pH fluctuations limited to 0.5 units prevent post-treatment erythema (redness).
• 7.5 mg of HA provides an immediate 15% volume boost during the first week.

As the density of the collagen fiber network increases by 1.2 times, light reflects more uniformly off the skin surface. This manifests as increased translucency and a shift from a dull, sallow undertone to a refreshed complexion. When the microscopic tissue thickness increases by 0.15 mm, the surface light refraction rate improves by approximately 10%. The microspheres boast a sphericity rating of 98.2%. This high degree of smoothness minimizes mechanical friction against surrounding cells. Upon contact, cells perceive the spheres as a natural physical presence rather than a harsh foreign body, significantly reducing inflammatory responses. Enhanced blood flow accelerates the transport of amino acids. With an abundant oxygen supply, the efficiency of fibroblast protein synthesis increases by roughly 25%. Consequently, every unit of PDLLA induces the maximum possible amount of endogenous collagen. Clinical measurements show a 0.4-second reduction in skin recoil time.

• 98.2% sphericity minimizes the physical risk of nodule formation.
• A 25% boost in cellular activity accelerates structural reorganization.
• The 0.4-second improvement in recoil time reflects significantly enhanced elastic fiber strength.

Visible pore reduction begins around Week 8. This occurs as new collagen fibers form tight rings around the pores, creating centripetal tension. Clinical data shows that as dermal tension increases, the diameter of “teardrop-shaped” sagging pores is physically reduced by 18% to 30%.

The Advantages of Micron-Scale Particle Size

Each of JuveLook contains 42.5 mg of PDLLA dry powder, which integrates with 6 to 8 ml of diluent after 30 seconds of manual agitation. This ensures roughly 5 million micro-particles per milliliter, locked within a 10 to 40-micron range. This precise sizing directly reduces injection resistance, allowing the suspension to flow smoothly through 32G with an internal diameter of just 0.16 mm. During the procedure, practitioners maintain an injection force of 15 to 20 Newtons. This consistent pressure ensures the microspheres are evenly distributed at a 1.5 mm depth without localized pooling. Because the particles are so fine, the injection angle can be lowered to 15–30 degrees, laying down approximately 50,000 micro-support points per square centimeter. This lattice-like dispersion constructs an invisible biological support web. The 10–40 μm diameter is specifically engineered to bypass the immune system’s “phagocytic window.” While macrophages typically prioritize foreign bodies under 20 μm, JuveLook’s particle distribution curve keeps the majority of particles within a safe range for sustained activity. A physical gap of approximately 50 μm is maintained between particles to prevent subcutaneous clumping, keeping the clinical probability of nodules below 0.1%.

Micron-scale particles perform exceptionally well in the periorbital (eye) area. Given that the skin here is only about 0.5 mm thick, traditional coarse particles often cause visible protrusions. JuveLook’s fine microspheres diffuse uniformly at a 1.0 mm depth, keeping surface irregularities within a margin of 0.05 mm. This precision allows fine lines under the eyes to be smoothed by internal structural support without any “foreign body” sensation. The internal honeycomb pores of the microspheres (1–5 μm) induce fibroblast anchoring within 72 hours. Electron microscopy shows a cell colonization rate exceeding 60% on the particle surfaces. This micro-scale physical induction triggers protein synthesis, raising dermal bioactivity markers by approximately 25% compared to untreated skin. The PDLLA molecular chains gradually vanish via hydrolysis over 12 to 18 months. The release rate of lactic acid monomers is kept constant at 0.05 μmol per mg per day, preventing a sudden accumulation of acidic material. Local osmotic pressure remains stable within the physiological range of 280 to 310 mOsm. As the material degrades, the physical space is entirely replaced by newborn collagen fiber bundles measuring 250 nm in diameter.

• Particles under 10 μm are limited to less than 3% to prevent premature lymphatic clearance.
• 30 nm Type III collagen peaks at Day 21, enhancing skin softness.
• 15% immediate hydration boost is provided by the 7.5 mg of non-crosslinked HA.
• A 0.15 mm increase in dermal thickness is quantified by Week 24.

Improvement in skin texture stems from the physical increase in underlying tissue density. When the number of fibers per square millimeter increases by over 150, surface pores contract due to centripetal pressure. Data shows that due to increased dermal tension, pores sagging from age shrink by an average of 22% in diameter. This structural shift improves skin light reflectance by 12% after 8 weeks. For neck lines, micron-scale particles are injected at a shallow 15-degree angle. This allows the suspension to follow the natural skin creases without forming lumps in the folds. With a molecular weight set above 100,000 Daltons, this physical support demonstrates excellent stability throughout a 540-day observation period.

The porous nature of the particle surfaces allows a protein adsorption rate of 4.5 mg per hour. This efficient biological interaction accelerates microcirculation renewal, while a slight expression of Vascular Endothelial Growth Factor (VEGF) improves oxygen supply. The transition from dull to translucent skin is rooted in these minute biochemical reactions occurring every minute. This robust blood supply provides the essential amino acids and energy required for collagen synthesis. The Ra (surface roughness) parameter drops from a baseline of 1.5 μm to 1.1 μm. This change is not dependent on the volume of an exogenous filler, but rather on a 20% gain in the strength of the skin’s own fiber network. Tensiometer tests show that tissue recovery time after pressure is shortened by 0.4 seconds. This physical optimization is based entirely on the reconstruction of the skin’s foundation rather than temporary swelling. To ensure industry-leading rigor, every batch must pass laser diffraction particle size analysis. Regardless of production variations, microsphere sphericity must remain constant at 98.2% or higher. This near-perfect spherical structure minimizes mechanical friction against micro-vessels, lowering the incidence of post-injection bruising. The 42.5 mg dosage maximizes efficacy within a strict safety margin.

• A protein adsorption rate of 4.5 mg/h accelerates tissue repair.
• A mean roughness of 1.1 μm represents a substantial refinement in skin feel.
• The 0.4s recoil optimization reflects significantly improved elastic fiber strength.
• The 98.2% spherical structure protects the homeostatic balance of the dermal microenvironment.

Degradation and Metabolic Timeline

The 42.5 mg of PDLLA in JuveLook undergoes a transformation spanning approximately 540 days. Moisture enters the material through 1-to-5-micron pores, gradually loosening the dense internal structure. The long-chain molecules, initially around 100,000 Daltons, are broken down bit by bit. During the first 4 weeks, changes are subtle as the local environment maintains an osmotic pressure of 280 to 310 mOsm. During this phase, the 7.5 mg of hyaluronic acid sustains baseline hydration. As the HA is metabolized between Days 7 and 14, the PDLLA microspheres take over, providing the scaffold for cellular colonization and activity.

By Day 30, microspheres are typically fully covered by cells. While the material mass has decreased by less than 5%, cellular activity at the surface is at its peak.

By Week 12, degradation accelerates as macro-molecules break into smaller fragments. Lactic acid is released at a steady rate of approximately 0.05 μmol per mg per day—a rhythmic release that avoids sudden metabolic spikes. This lactic acid enters the body’s metabolic system and is converted into carbon dioxide and water.

• Weeks 1–4: Hydration and environmental adaptation.
• Weeks 12–24: Accelerated degradation; significant collagen surge.
• Week 56: Approximately 70% of the material is metabolized.
• Week 72: Material is virtually entirely cleared from the body.

The PDLLA structure, composed of equal parts D-type and L-type isomers, allows for a degradation rate roughly 30% faster than single-isomer structures. This makes the residency time more predictable and minimizes long-term residues, keeping the nodule rate below 0.1%. The material mass decreases by approximately 6% per month. Simultaneously, new collagen gradually fills the vacated space. Under microscopic observation, the 40-micron voids are progressively occupied by 250 nm collagen fiber bundles.

Tracking data shows that after 18 months, dermal thickness increases by 0.15 to 0.18 mm. Even after the material has metabolized, the new structural framework remains.

During production, every batch is tested to ensure molecular weight stays between 100k and 150k Daltons. A deviation of more than 5% would disrupt the degradation rhythm; if it degrades too quickly, lactic acid concentrations could exceed 0.5 mmol in a short period, potentially causing local discomfort. At Week 24, the improvement in skin elasticity is most pronounced. Recoil time after pressure is approximately 0.4 seconds faster than baseline. This change is linked to the continuous release of trace signaling molecules during degradation, which stimulates the production of additional Type III collagen.

• Metabolic End-Products: $CO_2$ is exhaled via the lungs; water is excreted via the kidneys.
• Post-18 Months: No detectable residual material in the tissue.
• Week 36: Collagen alignment becomes more organized and uniform.
• Total Duration: pH fluctuations are strictly controlled within 0.5 units.

As the microspheres dissolve at a depth of 1.5 mm, they also trigger a slight improvement in local blood flow. Oxygen supply increases by approximately 15%. This enhanced circulation stabilizes the metabolic rate and leads to a more even skin tone over time. With a sphericity of 98.2%, the microspheres maintain their shape throughout the 18-month breakdown process, avoiding mechanical irritation to surrounding tissues. The energy released during this process is exceptionally stable, ensuring a smooth, non-irritating experience.

Long-term follow-ups show that even 2 years after the material has vanished, skin roughness remains around 1.1 μm—significantly better than the 1.5 μm pre-treatment baseline.

As the material reaches its final 10%, a stable collagen structure has already been established within the skin. This ensures there is no sudden “collapse” of support; the transition is seamless and natural. The 10-to-40-micron particle size ensures that even late-stage fragments are not cleared too quickly by the lymphatic system, keeping the metabolic process localized to the skin.

• Lactic acid is ultimately processed via the TCA (Krebs) cycle.
• Even after 90% of the material is gone, elasticity remains 18% higher than baseline.
• Lattice distribution ensures uniform degradation across the treated area.
• Every microsphere contributes actively to the total collagen yield.